Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
WuXi PharmaTech will spend $100 million...
WuXi PharmaTech received ISO 14001...
WuXi PharmaTech announced its new Suzhou...
WuXi PharmaTech reported impressive Q3...
Bristol-Myers Squibb announced a strategic partnership...
WuXi PharmaTech, one of China’s...
WuXi PharmaTech, the NY-listed CRO,...
WuXi PharmaTech plans to begin offering...
WuXi AppTec reported it has been given a...
WuXi PharmaTech, a leading China CRO,...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China